Type IV renal tubular acidosis and spironolactone therapy in the elderly
| Autor: | N. R. Colledge, J. E. O'Connell |
|---|---|
| Rok vydání: | 1993 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Urology Spironolactone Renal tubular acidosis chemistry.chemical_compound Internal medicine medicine Humans Aged Acidosis Aged 80 and over Renal tubule Chemotherapy Type IV renal tubular acidosis business.industry Metabolic acidosis Acidosis Renal Tubular General Medicine medicine.disease Endocrinology chemistry Toxicity Hyperkalemia Female medicine.symptom business Research Article |
| Zdroj: | Postgraduate Medical Journal. 69:887-889 |
| ISSN: | 1469-0756 0032-5473 |
| DOI: | 10.1136/pgmj.69.817.887 |
| Popis: | Summary Spironolactone therapy is a well-known cause of hyperkalaemia, but in susceptible patient, it may also be associated with metabolic acidosis. We report a case of severe renal tubular acidosis (Type IV) with life-threatening hyperkalaemia caused by spironolactone, and discuss the mechanisms by which this may occur. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|